摘要
新辅助治疗在提高可切除性结直肠癌患者的手术率和生存率方面取得一些可喜结果。以奥沙利铂、依立替康为基础联合化疗,在提高转移性结直肠癌患者手术率与生存率疗效已较为肯定。肝动脉介入治疗(如HAI、TACE等)在新辅助治疗中的应用疗效有待进一步研究。术前PVE和两步肝切除术可提高手术安全性和切除率。
Neoadjuvant therapy has shown clear benefits in the treatment of operable colorectal cancer. Systemic chemotherapy including new drugs such as CPT-11 and oxaliplatin has shown improved operation rate and survival rate. Intra-arterial hepatic treatment such as HAI and TACE needs the further research. PVE and two-stage hepatectomy can raise the operation safety and excision rates.
出处
《中华肿瘤防治杂志》
CAS
2006年第5期394-396,共3页
Chinese Journal of Cancer Prevention and Treatment
关键词
结直肠肿瘤
直肠肿瘤
综述文献
colorectal neoplasms
rectal neoplasms
review literature
